Singh Vasvi, Luthra Saurav, Elajami Tarec K, Welty Francine K
Department of Internal Medicine, Unity Health System, Rochester, New York, USA.
Department of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
BMJ Case Rep. 2015 Jan 6;2015:bcr2014207107. doi: 10.1136/bcr-2014-207107.
A 57-year-old Asian woman with type 2 diabetes mellitus, hypertension, obesity, dyslipidaemia and history of breast cancer, was referred to the cardiovascular health and lipid centre for evaluation and management of dyslipidaemia and NASH (Non-alcoholic steatohepatitis) in 2010. She originally had a detailed work up at the liver clinic for elevated liver enzymes, with no associated symptoms. Initial hepatic MRI on 22 January 2007 showed diffuse fatty infiltration quantitated at 15%. We counselled her on lifestyle modifications, including dietary measures and exercise, geared toward weight loss. Over the next 2 years, she lost 24.5 lbs; repeat hepatic MRI on 22 December 2011 showed 6% hepatic fat, which is within the normal range. This case demonstrates the efficacy of significant weight loss in the improvement and resolution of NASH. We believe that this is the first case report documenting this through liver MRI.
一名57岁的亚洲女性,患有2型糖尿病、高血压、肥胖症、血脂异常以及乳腺癌病史,于2010年被转诊至心血管健康与脂质中心,以评估和治疗血脂异常及非酒精性脂肪性肝炎(NASH)。她最初因肝酶升高在肝病诊所进行了详细检查,无相关症状。2007年1月22日的初次肝脏MRI显示弥漫性脂肪浸润,定量为15%。我们建议她进行生活方式调整,包括饮食措施和运动,以减轻体重。在接下来的两年里,她体重减轻了24.5磅;2011年12月22日的重复肝脏MRI显示肝脏脂肪含量为6%,处于正常范围内。该病例证明了显著体重减轻对改善和解决NASH的有效性。我们认为这是第一例通过肝脏MRI记录此情况的病例报告。